INTERVIEW Article
Discoveries Interview: Prof. Jack Lawler on the discovery and significance of thrombospondins
Read FULL ARTICLE (pdf) Summary, Citation & References DOI: 10.15190/d.2014.4
Dr. Jack Lawler is a Professor at Harvard Medical School and the Director of Division of Cancer Biology and Angiogenesis, Beth Israel Deaconess Medical Center, Boston, MA, USA.
He received his PhD in Physics from Boston College in 1976, and performed postdoctoral training at the Dana Farber Cancer Center. Over the past 30 years, Dr. Lawler's laboratory has utilized a wide range of technologies to elucidate the structure and function of the thrombospondins. He has authored over 200 publications and has co-authored the book "The Thrombospondin Gene Family". In 1996, Dr. Lawler joined the Department of Pathology at the Beth Israel Deaconess Medical Center where he is currently the Director of the Division of Cancer Biology and Angiogenesis and Professor of Pathology at Harvard Medical School. Read more
EXPERIMENTAL Articles
Novel insights into the mechanism of cell-based therapy after chronic myocardial infarction
Alexander Schuh, Britta Butzbach, Adelina Curaj, Sakine Simsekyilmaz, Octavian Bucur, Isabela Kanzler, Bernd Denecke, Simone Konschalla, Andreas Kroh, Tolga Taha Sönmez, Nikolaus Marx and Elisa A. Liehn
Read FULL ARTICLE (pdf) Abstract, Citation & References DOI: 10.15190/d.2014.1
Corresp. author's affiliation:
IMCAR, RWTH Aachen University, GermanyCorresp. author's affiliation:
St. Lukes, Roosevelt, and Beth Israel Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY, USADNA bending in the synaptic complex in V(D)J recombination: turning an ancestral transpososome upside down
Mihai Ciubotaru, Marius Surleac, Mihaela G. Musat, Andreea M. Rusu, Elena Ionita, Paul C. C. Albu
Read FULL ARTICLE (pdf) Abstract, Citation & References DOI: 10.15190/d.2014.5
Corresp. author's affiliation: Yale University School of Medicine, New Haven, CT, USA
Corresp. author's affiliation:
Central South University, Changsha, China
New agents for the treatment of lymphoid leukemia and lymphoma: Focus on Recent FDA Approvals
Andreea Lucia Stancu, Mitchell R. Smith and Alexandru Almasan
Read FULL ARTICLE (pdf) Abstract, Citation & References DOI: 10.15190/d.2014.6
Corresp. author's affiliation: Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA